FDA approves first marijuana-based epilepsy medication

The FDA has approved the nation’s first medication based on an active ingredient from marijuana. The drug, Epidiolex, is intended to treat seizures resulting from Dravet syndrome and Lennox-Gastaut syndrome, two rare forms of epilepsy. The medication has been approved for patients aged two years or older and marks the first time the agency has approved a drug derived from … Continue reading

No Responses to “FDA approves first marijuana-based epilepsy medication”

Post a Comment